Kenvue Supplements Proxy Disclosures Ahead of Merger Vote

Kenvue, Inc. ( (KVUE) ) just unveiled an announcement.

On November 2, 2025, Kenvue Inc. agreed to be acquired by Kimberly-Clark Corporation through a two-step merger that would make Kenvue a wholly owned subsidiary of Kimberly-Clark, and by December 16, 2025, the SEC had declared effective a registration statement supporting joint proxy materials for special shareholder meetings scheduled for January 29, 2026 to vote on the transaction. Since early December 2025, multiple purported Kenvue and Kimberly-Clark stockholders have filed lawsuits in federal and state courts in Wisconsin, New Jersey, New York and Delaware, along with sending demand letters, alleging that the preliminary and joint proxy statements omitted material information and asserting securities law and fiduciary duty violations, with plaintiffs seeking to enjoin the votes or the mergers until additional disclosures are made and to recover fees and costs. To reduce the risk of delays to closing and limit litigation costs, Kenvue has voluntarily supplemented the joint proxy statement/prospectus with extensive additional detail on the board’s strategic review process, advisory relationships, financial analyses and long-term projections for Kenvue, Kimberly-Clark and the combined company, while maintaining that these added disclosures are not legally required and reiterating the Kenvue board’s unanimous recommendation that shareholders vote in favor of the merger and related proposals.

The most recent analyst rating on (KVUE) stock is a Buy with a $19.50 price target. To see the full list of analyst forecasts on Kenvue, Inc. stock, see the KVUE Stock Forecast page.

Spark’s Take on KVUE Stock

According to Spark, TipRanks’ AI Analyst, KVUE is a Outperform.

Kenvue’s overall stock score is driven by its solid financial performance and attractive valuation, supported by a significant corporate event in the form of a merger with Kimberly-Clark. While technical analysis shows mixed signals, the strategic merger is a major positive factor, enhancing the company’s growth prospects.

To see Spark’s full report on KVUE stock, click here.

More about Kenvue, Inc.

Kenvue Inc. is a consumer health company focused on over-the-counter medicines, personal care and wellness products, operating in a global marketplace alongside large branded household and personal care peers such as Procter & Gamble, Unilever, Colgate-Palmolive and Haleon. Its business is evaluated by investors using measures such as adjusted EBITDA and unlevered free cash flow, and it is currently the subject of a strategic review that has led to a planned merger with Kimberly-Clark Corporation, a major player in tissue and personal care products.

Average Trading Volume: 40,484,049

Technical Sentiment Signal: Sell

Current Market Cap: $32.8B

For a thorough assessment of KVUE stock, go to TipRanks’ Stock Analysis page.